Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02658708 · ClinicalTrials.gov registry record · Phase 1
Bright Light on Fatigue in Women Being Treated for Breast Cancer
A Phase 1 study of Breast Cancer and Breast Neoplasms, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT02658708 is a Phase 1 study of Breast Cancer and Breast Neoplasms that has completed, run by Washington University School of Medicine. The registered enrollment target is 19 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02658708, a Phase 1 study of Breast Cancer and Breast Neoplasms, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed study will examine feasibility and implement therapeutic bright light that is tailored to the individual's circadian typology to estimate its therapeutic effects on sleep/wake patterns and fatigue in breast cancer patients undergoing chemotherapy.
Conditions Studied
Interventions
- OTHER Bright blue-green light using light visor cap
- OTHER Dim red light using light visor cap
- OTHER European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire
- OTHER Epworth Sleepiness Scale
- OTHER Pittsburgh Sleep Quality Index
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-10-12 |
| Est. Completion | 2017-05-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02658708
The ClinicalTrials.gov registry entry for NCT02658708 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Bright blue-green light using light visor cap is the first listed.
NCT02658708 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02658708 about?
NCT02658708 is a clinical study titled "Bright Light on Fatigue in Women Being Treated for Breast Cancer". This proposed study will examine feasibility and implement therapeutic bright light that is tailored to the individual's circadian typology to estimate its therapeutic effects on sleep/wake patterns and fatigue in breast cancer patients undergoing chemotherapy.
What is the current status of trial NCT02658708?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2015-10-12. Estimated completion is 2017-05-09.
What conditions does trial NCT02658708 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasms, Cancer of the Breast, Cancer of Breast.
What interventions are being tested in trial NCT02658708?
The interventions under investigation include: Bright blue-green light using light visor cap (OTHER), Dim red light using light visor cap (OTHER), European Organization for Research and Treatment of Cancer-Quality of Life Questionnaire (OTHER), Epworth Sleepiness Scale (OTHER), Pittsburgh Sleep Quality Index (OTHER).
Who is sponsoring clinical trial NCT02658708?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02658708 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VS-6766+Abema+Fulv in Met HR+/HER- BC
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.